Interleukin-3 is elevated in patients with coronary artery disease and predicts restenosis after percutaneous

Tanja Rudolph1, Klaus-Peter Schaps, Daniel Steven

  • 1Department of Cardiology, University Hospital Hamburg, Hamburg, Germany.

Insights

Interleukin-3 (IL-3) is elevated in coronary artery disease (CAD) patients, especially those undergoing angioplasty. Higher IL-3 levels predict restenosis, highlighting its role in chronic inflammation and atherosclerosis.

Area of Science:

  • Immunology
  • Cardiology
  • Inflammation Research

Background:

  • Interleukin-3 (IL-3) is synthesized by T-lymphocytes and implicated in chronic inflammation and atherosclerosis.
  • Limited data exists on IL-3 levels in patients with coronary artery disease (CAD).

Purpose of the Study:

  • To compare IL-3 concentrations in various CAD patient subsets and healthy controls.
  • To investigate the association between IL-3 levels and restenosis after percutaneous coronary intervention.

Main Methods:

  • Serum IL-3 and hs-CRP concentrations were measured in 205 CAD patients (stable angina, acute coronary syndrome, asymptomatic) and 41 controls.
  • Measurements were taken at baseline and at 6 weeks, 6, and 12 months post-intervention.
  • IL-3 levels were compared between groups and correlated with restenosis development.

Main Results:

  • Detectable IL-3 levels were more frequent in patients undergoing coronary angioplasty compared to asymptomatic CAD or control groups (21% vs. 8% and 1%, respectively).
  • Patients who developed symptomatic restenosis had significantly higher IL-3 levels than those without restenosis (45% vs. 17%).
  • IL-3 emerged as the sole independent predictor of restenosis in multivariate analysis; hs-CRP was elevated in ACS but did not correlate with IL-3.

Conclusions:

  • IL-3 is elevated in CAD patients, particularly those undergoing percutaneous coronary intervention.
  • Elevated IL-3 concentrations are predictive of symptomatic restenosis.
  • IL-3 plays a significant role in the inflammatory processes underlying CAD and restenosis.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...